Suzetrigine

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameSuzetrigine
Drug Alias NameJournavxVX-548
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit inhibitors
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsDiabetic peripheral neuropathyPain ThresholdAcute Pain +[9] 
Global Approved IndicationsAcute Pain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/01/30
Country/TerritoryUnited StatesNew ZealandAustralia +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesVertex Pharmaceuticals Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesAdventhealthLatigo Biotherapeutics IncWake Forest University Health Sciences +[6] 
Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathyPain ThresholdAcute Pain +[8] 
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG